Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 2, Randomized, Double Blind, Parallel Design Study Comparing the Efficacy and Safety of VI-0521 to Placebo in the Glycemic Management of Obese Diabetic Adults

NCT00486291 is registered in ClinicalTrials.gov with VIVUS LLC as lead sponsor.

NCT NCT00486291
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00486291 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 2, Randomized, Double Blind, Parallel Design Study Comparing the Efficacy and Safety of VI-0521 to Placebo in the Glycemic Management of Obese Diabetic Adults
Lead sponsor
VIVUS LLC
Phase
Phase 2
Overall status
Completed
Start date
June 30, 2007
Completion date
April 30, 2008
Enrollment
210 (actual)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

type 2 diabetes mellitus